# Study of Nicotine for Pain Associated With Chemotherapy-Induced Peripheral Neuropathy

> **NCT04468230** · PHASE2 · TERMINATED · sponsor: **Virginia Commonwealth University** · enrollment: 4 (actual)

## Conditions studied

- Neuropathy
- Peripheral Neuropathy
- Neuropathic Pain
- Chemotherapy-induced Peripheral Neuropathy

## Interventions

- **DRUG:** Nicotine Transdermal Patch

## Key facts

- **NCT ID:** NCT04468230
- **Lead sponsor:** Virginia Commonwealth University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-07-31
- **Primary completion:** 2022-05-31
- **Final completion:** 2022-05-31
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Low Accrual Rate
- **Last updated:** 2023-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04468230

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04468230, "Study of Nicotine for Pain Associated With Chemotherapy-Induced Peripheral Neuropathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04468230. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*